In addition, a study conducted by Pyonteck et al. (25) proposed that tumor-associated macrophage could serve as a promising therapeutic target for proneural gliomas and demonstrated that CSF-1R inhibition might become a potential therapeutic strategy for patients with glioma. This evidence concerns the gene CSF1R and central nervous system cancer.